Cargando…

Comparison of viscous budesonide and fluticasone in the treatment of patients with eosinophilic esophagitis: a systematic review and meta-analysis

BACKGROUND: Steroids are an important pharmacologic treatment in patients with eosinophilic esophagitis (EoE). Fluticasone and budesonide are the 2 main steroid medications used in EOE treatment, but current United States (US) guidelines do not recommend one agent over the other. In this study, we c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Numan, Laith, Kalot, Mohamad A., Brotherton, Tim, Tarakji, Ahmad, Hamdeh, Shadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433255/ https://www.ncbi.nlm.nih.gov/pubmed/37664238 http://dx.doi.org/10.20524/aog.2023.0822

Ejemplares similares

Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis
por: Ahmet, Alexandra, et al.
Publicado: (2016)

A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis
por: Oliva, Salvatore, et al.
Publicado: (2019)

A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature
por: Warzecha, Joanna, et al.
Publicado: (2022)

Budesonide and fluticasone and adrenal suppression
por: Fouda, Mona A, et al.
Publicado: (2012)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
por: Belchamber, Kylie BR, et al.
Publicado: (2018)

Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
por: Casiraghi, Antonella, et al.
Publicado: (2020)

A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide
por: Liu, Xiaopei, et al.
Publicado: (2022)

Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis
por: Gupta, Sandeep K., et al.
Publicado: (2022)

Budesonide and fluticasone propionate differentially affect the airway epithelial barrier
por: Heijink, I. H., et al.
Publicado: (2016)

Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis
por: Andrist, Caroline Michèle, et al.
Publicado: (2020)

Eosinophilic cholangitis treatment with budesonide
por: De Roza, Marianne Anastasia, et al.
Publicado: (2017)

Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence
por: Miehlke, Stephan, et al.
Publicado: (2020)

Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies
por: Rawla, Prashanth, et al.
Publicado: (2018)

Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies
por: Lodise, Thomas P, et al.
Publicado: (2020)

Comparison of the effect of high-dose inhaled budesonide and fluticasone on adrenal function in patients with severe chronic obstructive pulmonary disease
por: Fahim, Ahmed, et al.
Publicado: (2012)

Psychometric validation of the Dysphagia Symptom Questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension
por: Hudgens, Stacie, et al.
Publicado: (2017)

Reply to: “Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies” [Letter]
por: Barnes, Neil C, et al.
Publicado: (2021)

Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate
por: Provost, Karin A., et al.
Publicado: (2019)

Nebulized step-down budesonide vs. fluticasone in infantile asthma: A retrospective cohort study
por: Wu, Zhimin, et al.
Publicado: (2020)

Nebulized step-down budesonide vs. fluticasone in infantile asthma: A retrospective cohort study
por: Wu, Zhimin, et al.
Publicado: (2020)

Efficacy of intranasal fluticasone propionate and budesonide in management of allergic rhinitis—a prospective comparative study
por: Shankari, P. Kiruba, et al.
Publicado: (2021)

Comment on Casiraghi et al. “Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis” 2020, 12, 211
por: Zur, Eyal
Publicado: (2020)

Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis
por: Mukkada, Vincent A., et al.
Publicado: (2023)

Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management
por: Daley-Yates, Peter, et al.
Publicado: (2023)

In Vitro Effects of Budesonide on Eosinophil-Basophil Lineage Commitment
por: Cyr, Michael M, et al.
Publicado: (2008)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006)

A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation
por: Ringdal, N., et al.
Publicado: (1996)

Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
por: Choi, Jae-Hwa, et al.
Publicado: (2021)

Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
por: Casiraghi, Antonella, et al.
Publicado: (2020)

In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices
por: Nave, Ruediger, et al.
Publicado: (2007)

Adrenal suppression in an asthmatic presenting after change from high dose inhaled fluticasone propionate to inhaled budesonide
por: Abdurahman, Zainab B, et al.
Publicado: (2010)

Beclomethasone Has Lesser Suppressive Effects on Inflammation and Antibacterial Immunity Than Fluticasone or Budesonide in Experimental Infection Models
por: Kamal, Faisal, et al.
Publicado: (2020)

Correction to: Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management
por: Daley-Yates, Peter, et al.
Publicado: (2023)

Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis
por: Cope, Shannon, et al.
Publicado: (2012)

Timely Endoscopic Recognition of Aortoesophageal Fistula With Successful Treatment
por: Brotherton, Tim, et al.
Publicado: (2023)

Efficacy of treatment with montelukast, fluticasone propionate and budesonide liquid suspension for the prevention of recurrent asthma paroxysms in children with wheezing disorders
por: Ding, Bo, et al.
Publicado: (2019)

Response to the Letter to the Editor Regarding “Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies” [Response to Letter]
por: Lodise, Thomas P, et al.
Publicado: (2021)

Eosinophilic Gastroenteritis-associated Duodenal Ulcer Successfully Treated with Crushed Budesonide
por: Kubo, Kimitoshi, et al.
Publicado: (2020)

Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life
por: Price, David B, et al.
Publicado: (2007)

Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study
por: Yu, Iseul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_itb2k0djq6mn7gjk2pv8bjs5ja